iPSC-Derived Cells

Induced Pluripotent Stem Cells (iPSCs) are a groundbreaking innovation in the field of regenerative medicine and biomedical research. Derived from human somatic cells that have been reprogrammed to a pluripotent state, iPSCs possess the remarkable ability to differentiate into virtually any cell type in the body, offering a myriad of benefits for both research and clinical applications.

High Purity: Our iPSCs ensure a homogeneous and focused cell population, providing a clean slate for researchers to study the intricacies of cellular development and function without the interference of other cell types.

Versatile Differentiation: These cells maintain the pluripotency to differentiate into a wide array of cell lineages, including neurons, cardiomyocytes, and macrophages, offering a versatile tool for studying various aspects of cellular biology and disease pathology.

Customizability: The adaptability of iPSCs is underscored by their derivation from a diverse array of donor somatic cells, allowing for the exploration of genetic variations and the tailoring of personalized therapeutic strategies.

Scalability: With the capability to produce large quantities of iPSCs, researchers can undertake high-throughput screening and other large-scale research endeavors, accelerating the pace of drug discovery and therapeutic development.

Clinical-Grade Options: In addition to research-grade iPSCs, we also provide clinical-grade iPSCs, which are manufactured under strict Good Manufacturing Practice (GMP) conditions. These cells are ideal for advanced therapeutic development, clinical trials, and potential direct application in regenerative medicine.

Regenerative Medicine Potential: iPSCs are at the forefront of regenerative medicine, with the potential to replace damaged tissues and treat diseases that were once considered incurable. Their use in autologous cell therapies could minimize the risk of immune rejection and open new avenues for treating conditions like neurodegenerative diseases, heart disease, and diabetes.

Research Applications: Beyond regenerative medicine, iPSCs serve as invaluable tools for investigating the fundamental biology of various cell types, understanding the mechanisms of disease, and developing new treatments for a wide range of conditions.



  • Cat.NO:iOPC-01
  • Cell Quantity:1Vial ≥ 1×10^6cells/vial
  • iOPC cells are derived from human induced pluripotent stem cells through induction and differentiation by small molecules and cytokines. They can form oligodendrocytes and possess the abilities of myelination and factor secretion.
  • From $ 483.1
  • Cat.NO:iNPC-01
  • Cell Quantity: 1Vial ≥ 1×10^6cells/vial
  • The iNPCs from iCell International, derived from human iPSCs and can be used to construct models of neurological diseases, conduct research on neural development mechanisms, and explore nerve repair and other aspects.
  • From $ 531.0
  • Cat.NO:iCM-01
  • Cell Quantity: 1Vial ≥ 1×10^6cells/vial
  • The iCardiomyocytes (iCMs) from iCell International, derived from human iPSCs, are a purified population of research-grade cardiomyocytes with various applications in disease modeling, drug discovery, safety testing, and regenerative medicine.
  • From $ 451.5
  • Cat.NO:iRPE-01
  • Cell Quantity: 1Vial ≥ 1×10^6cells/vial
  • The iPSC-derived Retinal Pigment Epithelium cells(iRPE) from iCell International, derived from human iPSCs and can be used in disease research, drug discovery, safety and toxicity testing, and regenerative medicine.
  • From $ 532.0
  • Cat.NO:iNK-01
  • Cell Quantity: 1Vial ≥ 1×10^6cells/vial
  • The iNK from iCell International, derived from human iPSCs, are a highly pure population of research-grade NK cells offered in commercial quantities and possessing key features ideal for research and therapeutic development.
  • From $ 499.4